Search research articles
Contact Us
Filters
Showing results (241-250 of 320) with videos related to
Page
of 32
Sort By:
Archives of Internal Medicine
|
February 1, 1980
Echocardiographic systolic time intervals. Left ventricular performance in coronary artery disease
R J Chilton, R A Oliveros, B S Stutts, et al.
Neuroreport
|
December 19, 1998
Short CAG repeats within the hSKCa3 gene associated with schizophrenia: results of a family-based study
G Stöber, S Jatzke, J Meyer, et al.
Southern Medical Journal
|
November 1, 1982
Unusual response to intravenous verapamil in a patient with atrial fibrillation
R A Oliveros, W B Kruyer, R J Chilton, et al.
Psychopharmacology
|
January 1, 1989
Plasma moclobemide and metabolites: lack of correlation with clinical response and biogenic amines
J Fritze, G Laux, E Sofic, et al.
The American Journal of Cardiology
|
April 1, 1983
Ischemia-associated intraventricular conduction disturbances during exercise testing as a predictor of proximal left anterior descending coronary artery disease
K J Boran, R A Oliveros, C A Boucher, et al.
Biological Psychiatry
|
June 22, 1999
Functional PAX-6 gene-linked polymorphic region: potential association with paranoid schizophrenia
G Stöber, Y V Syagailo, O Okladnova, et al.
Neuroscience Letters
|
February 19, 1993
Adenosine A1 receptors in human hippocampus: inhibition of [3H]8-cyclopentyl-1,3-dipropylxanthine binding by antagonist drugs
J Deckert, W Berger, K Kleopa, et al.
American Journal of Medical Genetics
|
April 18, 1997
Neuronal nicotinic acetylcholine receptor alpha 4 subunit (CHRNA4) and panic disorder: an association study
O K Steinlein, J Deckert, M M Nöthen, et al.
Neuroscience Letters
|
March 3, 1995
Regional differences in the interaction of the excitotoxins domoate and L-beta-oxalyl-amino-alanine with [3H]kainate binding sites in human hippocampus
G Künig, J Hartmann, F Krause, et al.
Journal of Neural Transmission
|
January 1, 1984
The effect of neuroleptic treatment and of high dosage diazepam therapy on beta-endorphin immunoreactivity in plasma of schizophrenic patients
C Gramsch, H M Emrich, S John, et al.
Page
of 32
Search research articles
Search
Showing results (241-250 of 320) with videos related to
Sort By:
Page
of 32
Archives of Internal Medicine
|
February 1, 1980
Echocardiographic systolic time intervals. Left ventricular performance in coronary artery disease
R J Chilton, R A Oliveros, B S Stutts, et al.
Neuroreport
|
December 19, 1998
Short CAG repeats within the hSKCa3 gene associated with schizophrenia: results of a family-based study
G Stöber, S Jatzke, J Meyer, et al.
Southern Medical Journal
|
November 1, 1982
Unusual response to intravenous verapamil in a patient with atrial fibrillation
R A Oliveros, W B Kruyer, R J Chilton, et al.
Psychopharmacology
|
January 1, 1989
Plasma moclobemide and metabolites: lack of correlation with clinical response and biogenic amines
J Fritze, G Laux, E Sofic, et al.
The American Journal of Cardiology
|
April 1, 1983
Ischemia-associated intraventricular conduction disturbances during exercise testing as a predictor of proximal left anterior descending coronary artery disease
K J Boran, R A Oliveros, C A Boucher, et al.
Biological Psychiatry
|
June 22, 1999
Functional PAX-6 gene-linked polymorphic region: potential association with paranoid schizophrenia
G Stöber, Y V Syagailo, O Okladnova, et al.
Neuroscience Letters
|
February 19, 1993
Adenosine A1 receptors in human hippocampus: inhibition of [3H]8-cyclopentyl-1,3-dipropylxanthine binding by antagonist drugs
J Deckert, W Berger, K Kleopa, et al.
American Journal of Medical Genetics
|
April 18, 1997
Neuronal nicotinic acetylcholine receptor alpha 4 subunit (CHRNA4) and panic disorder: an association study
O K Steinlein, J Deckert, M M Nöthen, et al.
Neuroscience Letters
|
March 3, 1995
Regional differences in the interaction of the excitotoxins domoate and L-beta-oxalyl-amino-alanine with [3H]kainate binding sites in human hippocampus
G Künig, J Hartmann, F Krause, et al.
Journal of Neural Transmission
|
January 1, 1984
The effect of neuroleptic treatment and of high dosage diazepam therapy on beta-endorphin immunoreactivity in plasma of schizophrenic patients
C Gramsch, H M Emrich, S John, et al.
Page
of 32